Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.13T | 1.43T | 1.36T | 1.16T | 1.19T | 1.05T | Gross Profit |
2.13T | 2.36T | 1.36T | 1.16T | 1.19T | 1.05T | EBIT |
450.31B | 1.07T | 344.63B | 257.84B | 202.20B | 110.50B | EBITDA |
-7.67B | 623.70B | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
453.16B | 442.56B | 340.37B | 251.10B | 183.84B | 95.66B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
495.94B | 3.55T | 764.89B | 807.23B | 1.08T | 1.03T | Total Assets |
7.48T | 23.64T | 19.58T | 17.53T | 15.74T | 13.77T | Total Debt |
1.84T | 2.01T | 1.89T | 1.62T | 1.44T | 2.14T | Net Debt |
1.35T | 108.69B | 526.05B | -215.23B | -36.71B | 859.99B | Total Liabilities |
6.69T | 20.94T | 17.37T | 15.65T | 14.07T | 12.48T | Stockholders Equity |
764.30B | 2.56T | 2.14T | 1.82T | 1.58T | 1.23T |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.54T | -62.39B | 562.51B | 1.36T | 776.91B | Operating Cash Flow |
0.00 | 1.57T | -37.71B | 581.11B | 1.38T | 795.65B | Investing Cash Flow |
0.00 | -1.46T | -680.05B | -393.21B | -629.87B | -423.08B | Financing Cash Flow |
0.00 | 137.65B | 247.91B | 174.51B | -546.67B | 29.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $120.69B | 20.02 | 17.89% | 0.59% | 22.15% | 12.13% | |
76 Outperform | $68.58B | 9.69 | 20.65% | 5.10% | -7.01% | 15.18% | |
76 Outperform | $60.93B | 12.80 | 8.73% | 3.84% | -2.65% | -14.84% | |
73 Outperform | $173.48B | 22.40 | 14.51% | 0.80% | 13.13% | 0.54% | |
70 Outperform | $27.27B | 8.70 | 10.61% | 1.07% | -8.55% | 13.58% | |
70 Outperform | $20.21B | 16.83 | 10.89% | 3.81% | -3.94% | 31.52% | |
64 Neutral | $12.82B | 9.87 | 7.67% | 17000.34% | 12.39% | -5.85% |